Search
for

    Glossary Mycophenolate Mofetil

    immunosuppressive drug used to prevent organ transplant rejection

    Mycophenolate Mofetil, often known as CellCept, is an immunosuppressive medication commonly used to prevent organ rejection in transplant patients. It works by inhibiting the proliferation of T and B lymphocytes, which are crucial components of the immune response, thereby reducing the likelihood of the body attacking the transplanted organ.

    Sort by

    Research 30 of 517

    1. Efficacy and safety of mycophenolate mofetil for lichen planopilaris Journal of The American Academy of Dermatology · 2010 · 66 citations
    2. Comparison of Systemic Mycophenolate Mofetil with Topical Clobetasol in Lichen Planopilaris: A Parallel-Group, Assessor- and Analyst-Blinded, Randomized Controlled Trial American journal of clinical dermatology · 2015 · 26 citations
    3. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis Clinical and Molecular Hepatology · 2016 · 12 citations
    4. Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication Journal of the South African Veterinary Association · 2010 · 11 citations
    5. [Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis]. PubMed · 2012 · 2 citations
    6. Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study Asian Journal of Medical Sciences · 2025 · 1 citations
    7. BH09 Mycophenolate mofetil in the management of lichen planus pigmentosus in a woman with frontal fibrosing alopecia British Journal of Dermatology · 2024 · 1 citations
    8. Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice Annals of Medicine · 2025
    9. SIDE EFFECTS OF CYCLOSPORINE COMPARED TO TACROLIMUS AMONG YEMENI KIDNEY TRANSPLANT PATIENTS WHO SHARE THE SAME ADJUVANT AGENTS: MYCOPHENOLATE MOFETIL AND PREDNISONE Universal Journal of Pharmaceutical Research · 2020
    10. Efficacy and Safety of Treatment with Combine Mycophenolate Mofetil and Corticosteroid for Lupus Nephritis:A Multicenter Open-label Study Zhonghua linchuang mianyi he biantai fanying zazhi · 2008
    11. The successful treatment of nephrogenic fibrosing dermopathy (NFD) with mycophenolate mofetil (MMF) Journal of The American Academy of Dermatology · 2005
    12. Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis Arthritis Research & Therapy · 2006 · 137 citations
    13. P14 Mycophenolate mofetil in patients with autoimmune hepatitis intolerant to azathioprine Gut · 2010
    14. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology · 2017 · 213 citations
    15. Lichen planus International Journal of Dermatology · 2009 · 155 citations
    16. Management of primary cicatricial alopecias: options for treatment British Journal of Dermatology · 2008 · 98 citations
    17. Immunosuppressive treatment for proliferative lupus nephritis Cochrane library · 2018 · 86 citations
    18. Safety of dermatologic medications in pregnancy and lactation Journal of The American Academy of Dermatology · 2014 · 73 citations
    19. Early Diagnosis and Treatment of Discoid Lupus Erythematosus The Journal of the American Board of Family Medicine · 2009 · 61 citations
    20. Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis Multiple Sclerosis and Related Disorders · 2019 · 54 citations
    21. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination Kidney International · 2021 · 52 citations
    22. Lichen Planopilaris: Retrospective Study and Stepwise Therapeutic Approach Archives of dermatology · 2009 · 43 citations
    23. Acquired scalp alopecia. Part II: A review Australasian Journal of Dermatology · 1999 · 37 citations
    24. Management of ‘refractory’ skin disease in patients with lupus erythematosus Best Practice & Research Clinical Rheumatology · 2005 · 30 citations
    25. Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia JAAD case reports · 2015 · 24 citations
    26. Commentary: Treatment of lichen planopilaris Journal of The American Academy of Dermatology · 2010 · 23 citations
    27. ADVANCES IN PSORIASIS THERAPY Dermatologic Clinics · 2000 · 20 citations
    28. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab Journal of the Formosan Medical Association · 2019 · 15 citations
    29. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects Anais Brasileiros de Dermatologia · 2014 · 15 citations
    30. Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics Arthritis & Rheumatology · 2024 · 14 citations